These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 29794033)
1. Prediction of response to drug therapy in psychiatric disorders. Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH Open Biol; 2018 May; 8(5):. PubMed ID: 29794033 [TBL] [Abstract][Full Text] [Related]
2. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine. Pisanu C; Heilbronner U; Squassina A Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107 [TBL] [Abstract][Full Text] [Related]
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
4. The implications of the shared genetics of psychiatric disorders. O'Donovan MC; Owen MJ Nat Med; 2016 Nov; 22(11):1214-1219. PubMed ID: 27783064 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA and Posttranscriptional Dysregulation in Psychiatry. Geaghan M; Cairns MJ Biol Psychiatry; 2015 Aug; 78(4):231-9. PubMed ID: 25636176 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Biomarkers and Their Applications in Psychiatry. Kam H; Jeong H Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33266292 [TBL] [Abstract][Full Text] [Related]
8. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic aspects of bipolar disorder: An update. Budde M; Degner D; Brockmöller J; Schulze TG Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679 [TBL] [Abstract][Full Text] [Related]
11. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis. Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767 [TBL] [Abstract][Full Text] [Related]
12. miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders. Tsermpini EE; Kalogirou CI; Kyriakopoulos GC; Patrinos GP; Stathopoulos C Pharmacogenomics J; 2022 Jul; 22(4):211-222. PubMed ID: 35725816 [TBL] [Abstract][Full Text] [Related]
13. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235 [TBL] [Abstract][Full Text] [Related]
15. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity. Rudan I Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745 [TBL] [Abstract][Full Text] [Related]
16. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. Goud Alladi C; Etain B; Bellivier F; Marie-Claire C Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287754 [TBL] [Abstract][Full Text] [Related]
17. Clock Genes and Altered Sleep-Wake Rhythms: Their Role in the Development of Psychiatric Disorders. Charrier A; Olliac B; Roubertoux P; Tordjman S Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468274 [TBL] [Abstract][Full Text] [Related]
18. A computational algorithm for personalized medicine in schizophrenia. Lee BS; McIntyre RS; Gentle JE; Park NS; Chiriboga DA; Lee Y; Singh S; McPherson MA Schizophr Res; 2018 Feb; 192():131-136. PubMed ID: 28495491 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in psychiatry: implications for practice. Moore TR; Hill AM; Panguluri SK Recent Pat Biotechnol; 2014; 8(2):152-9. PubMed ID: 25185985 [TBL] [Abstract][Full Text] [Related]
20. Personalized medicine in major depressive disorder -- opportunities and pitfalls. Miller DB; O'Callaghan JP Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]